Progress and Challenges of Amniotic Fluid Derived Stem Cells in Therapy of Ischemic Heart Disease
Cardiovascular disease is the leading cause of deaths worldwide, claiming an estimated total of 17.9 million lives each year, of which one-third of the people are under the age of 70 years. Since adult cardiomyocytes fail to regenerate, the heart loses the ability to repair itself after an injury, m...
Main Authors: | Yi-Hsien Fang, Saprina P. H. Wang, Hsien-Yuan Chang, Pei-Jung Yang, Ping-Yen Liu, Yen-Wen Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/1/102 |
Similar Items
-
Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege
by: Yi-Hsien Fang, et al.
Published: (2020-03-01) -
A comprehensive review of the amniotic membrane and amniotic fluid
by: Brazzo, Joseph Anthony
Published: (2016) -
Amniotic fluid as a source of engraftable stem cells
by: Cesar V Borlongan
Published: (2017-01-01) -
Activity of p53 in human amniotic fluid stem cells increases their potentiality as a candidate for stem cell therapy
by: Blaise Cozene, et al.
Published: (2019-01-01) -
Human Amniotic Fluid Stem Cells: General Characteristics and Potential Therapeutic Applications
by: Seyed Mehdi Hoseini, et al.
Published: (2021-02-01)